Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
VGHCX vs HRTS
Shared holdings
25
VGHCX covered by HRTS
48.60%
HRTS covered by VGHCX
48.60%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
VGHCX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 9.78% | |
| ASTRAZENECA PLC | 5.50% | |
| MERCK & CO | 5.09% | |
| UNITEDHEALTH GRP | 3.49% | |
| JOHNSON&JOHNSON | 3.11% | |
| EDWARDS LIFESCIENCES CORP | 3.11% | |
| GSK PLC | 2.99% | |
| DANAHER CORP | 2.70% | |
| ABBOTT LABS | 2.58% | |
| INTUITIVE SURGICAL INC | 2.50% | |
| ARGENX SE | 2.50% | |
| CENCORA INC | 2.41% | |
| UCB SA | 2.35% | |
| ABBVIE INC | 2.30% | |
| MEDTRONIC PLC | 2.25% | |
| VERTEX PHARMACEUTICALS INC | 1.91% | |
| CVS HEALTH CORP | 1.85% | |
| ELEVANCE HEALTH INC | 1.66% | |
| CARDINAL HEALTH INC | 1.56% | |
| NOVARTIS AG-REG | 1.44% | |
| ROCHE HLDG-GENUS | 1.40% | |
| BIOGEN INC | 1.34% | |
| GALDERMA GROUP A | 1.25% | |
| OTSUKA HOLDINGS | 1.21% | |
| AGILENT TECHNOLOGIES INC | 1.19% | |
| HCA HEALTHCARE INC | 1.16% | |
| CHUGAI PHARMA CO | 1.15% | |
| ALNYLAM PHARMACEUTICALS INC | 1.13% | |
| GENMAB AS | 1.12% | |
| UNITED THERAPEUTICS CORP DEL | 1.07% | |
| THERMO FISHER SCIENTIFIC INC | 1.04% | |
| BOSTON SCIENTIFIC CORP | 0.98% | |
| SHIONOGI & CO | 0.98% | |
| DEXCOM INC | 0.87% | |
| DAIICHI SANKYO | 0.86% | |
| IONIS PHARMACEUTICALS INC | 0.80% | |
| BRISTOL-MYERS SQUIBB CO | 0.75% | |
| STRYKER CORP | 0.71% | |
| QIAGEN NV | 0.70% | |
| STERIS PLC | 0.68% | |
| CYTOKINETICS INC | 0.65% | |
| ASCENDIS PHA-ADR | 0.64% | |
| STRUCTURE THERAPEUTICS INC DEPOSITARY RECEIPT | 0.63% | |
| BOA-MTG TRIPARTY REPO | 0.61% | |
| EISAI CO LTD | 0.61% | |
| REGENERON PHARMACEUTICALS INC | 0.60% | |
| REVOLUTION MEDICINES INC | 0.59% | |
| AVANTOR INC | 0.57% | |
| ICON PLC | 0.56% | |
| NOVO NORDISK-B | 0.53% |
HRTS (Feb. 28, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 10.02% | |
| Roche Holding AG | 5.47% | |
| JOHNSON&JOHNSON | 4.86% | |
| ASTRAZENECA PLC | 4.82% | |
| MERCK & CO | 4.24% | |
| THERMO FISHER SCIENTIFIC INC | 3.90% | |
| UNITEDHEALTH GRP | 3.85% | |
| GILEAD SCIENCES INC | 3.62% | |
| Novartis AG (Registered) | 3.62% | |
| ABBOTT LABS | 3.37% | |
| VERTEX PHARMACEUTICALS INC | 3.21% | |
| ABBVIE INC | 2.96% | |
| DANAHER CORP | 2.92% | |
| BOSTON SCIENTIFIC CORP | 2.47% | |
| MEDTRONIC PLC | 2.37% | |
| BRIDGEBIO PHARMA INC | 2.23% | |
| REVOLUTION MEDICINES INC | 2.22% | |
| BRISTOL-MYERS SQUIBB CO | 2.17% | |
| MCKESSON CORP | 2.16% | |
| NOVO NORDISK-B | 2.15% | |
| AMGEN INC | 2.10% | |
| CHUGAI PHARMA CO | 2.06% | |
| REGENERON PHARMACEUTICALS INC | 2.02% | |
| EDWARDS LIFESCIENCES CORP | 1.86% | |
| TEVA PHARMACEUTICAL IND ADR | 1.62% | |
| CYTOKINETICS INC | 1.48% | |
| INTUITIVE SURGICAL INC | 1.47% | |
| MASIMO CORP | 1.36% | |
| DEXCOM INC | 1.29% | |
| MADRIGAL PHARMACEUTICALS INC | 1.21% | |
| INSMED INC | 1.19% | |
| ALNYLAM PHARMACEUTICALS INC | 1.19% | |
| INSULET CORP | 1.04% | |
| ARROWHEAD PHARMACEUTICALS INC | 1.03% | |
| VIKING THERAPEUTICS INC | 0.85% | |
| IONIS PHARMACEUTICALS INC | 0.83% | |
| SCHOLAR ROCK HOLDING CORP | 0.78% | |
| Ascendis Pharma A/S | 0.75% | |
| CRINETICS PHARMACEUTICALS INC | 0.64% | |
| FIRST AM-TR OB-X | 0.59% | |
| NEUROCRINE BIOSCIENCES INC | 0.57% | |
| ZEALAND PHARMA A | 0.56% | |
| GUBRA A/S | 0.51% | |
| INTELLIA THERAPEUTICS INC | 0.35% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.